EB病毒相关胃癌揭示PIK3CA突变的瘤内异质性
该研究在中欧胃癌队列中验证EB病毒相关胃癌(EBVaGC)的PIK3CA突变富集,并评估瘤内异质性。484例胃癌中22例EBER阳性,EBVaGC中PIK3CA热点突变显著更常见(P < 0.001)。EBVaGC扩展测序显示14%的原发瘤存在3至5种不同PIK3CA基因型,且相应淋巴结转移灶亦存在异质性。作者结论认为组织活检评估EBV状态可能存在采样误差风险,并首次报道胃癌PIK3CA突变的瘤内异质性。
要点
- 484例胃癌中22例EBER阳性,均为潜伏I型。
- EBVaGC中PIK3CA外显子9/20热点突变显著更常见(P < 0.001)。
- EBVaGC中14%原发瘤存在3至5种不同PIK3CA基因型,淋巴结转移灶亦见异质性。
核心结论
- EBVaGC中PIK3CA突变富集得到验证,且存在瘤内异质性。
- 组织活检评估EBV状态可能存在采样误差风险,可能妨碍临床分子分型。
- 首次报道胃癌PIK3CA突变的瘤内异质性,PIK3CA突变型和野生型亚克隆可独立转移至不同区域淋巴结。
研究设计与样本
- 中欧胃癌队列研究,第一步484例胃癌采用EBER原位杂交和焦磷酸测序筛查EBV及PIK3CA外显子9/20热点突变。
- 第二步对所有EBVaGC及96例相应淋巴结转移灶进行PIK3CA扩展测序(含二代测序)。
主要发现
- 22例胃癌EBER阳性,均为潜伏I型;18%的EBVaGC存在EBER阳性瘤内异质性。
- 23例胃癌携带PIK3CA外显子9或20热点突变,在EBVaGC中显著更常见(P < 0.001)。
- EBVaGC扩展测序显示14%的原发瘤在同一肿瘤的不同组织学和空间区域存在3至5种不同PIK3CA基因型(包括野生型)。
- 相应淋巴结转移灶中也存在PIK3CA突变的瘤内异质性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent whole-genome sequencing identified four molecular subtypes of gastric cancer (GC), of which the subgroup of Epstein-Barr virus-associated GC (EBVaGC) showed a significant enrichment of PIK3CA mutations. We here aimed to validate independently the enrichment of PIK3CA mutations in EBVaGC of a Central European GC cohort, to correlate EBV status with clinico-pathological patient characteristics and to test for a major issue of GC, intratumoral heterogeneity. PATIENTS AND METHODS: In a first step, 484 GCs were screened for EBV and PIK3CA hot spot mutations of exon 9/20 using EBER in situ hybridization and pyrosequencing, respectively. Secondly, an extended sequencing of PIK3CA also utilizing next generation sequencing was carried out in all EBVaGCs and 96 corresponding lymph node metastases. RESULTS: Twenty-two GCs were EBER-positive, all being of latency type I. Intratumoral heterogeneity of EBER-positivity was found in 18% of EBVaGCs. Twenty-three GCs held PIK3CA mutations in hot spot regions of exon 9 or 20, being significantly more common in EBVaGCs (P < 0.001). Subsequent extended sequencing of PIK3CA of EBVaGCs showed that 14% harvested three to five different PIK3CA genotypes (including wildtype) in the same primary tumor, albeit in histologically and spatially distinct tumor areas, and that intratumoral heterogeneity of PIK3CA was also present in the corresponding lymph node metastases. CONCLUSIONS: Our findings unravel issues of tumor heterogeneity and illustrate that the assessment of the EBV status in tissue biopsies might carry the risk of sampling errors, which may significantly hamper adequate molecular tumor classification in a more clinical setting. Moreover, this is the first report of intratumoral heterogeneity of PIK3CA mutations in GC, and our findings lead to the conclusion that PIK3CA mutant and -wildtype tumor subclones are skilled to metastasize independently to different regional lymph nodes.
引用
- Böger C, Krüger S, Behrens HM, et al. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations. Ann Oncol. 2017. PMID: 28453696. doi:10.1093/annonc/mdx047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。